Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Stocks Mixed After Fed Decision, Jobs Data
Mario Veneroso, partner & wealth manager with Kingsview Asset Management, joined Cheddar News to discuss Monday's trading session following last week's Fed decision to hike rates as well as Friday's jobs data.
Load More